Medtronic And The Role In Tax Of Unspecified Methods

Ryan Finley argues that while there are many possible grounds for appealing the bizarre transfer pricing method endorsed in Medtronic II, directly challenging the reclassification of specified methods as unspecified methods may be the most worthwhile.